Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2002 7
2003 6
2004 9
2005 3
2006 2
2009 4
2010 3
2011 2
2012 3
2014 3
2015 1
2016 3
2017 2
2018 2
2019 5
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Introduction: why a supplement on taxanes?
Muggia FM. Muggia FM. Anticancer Drugs. 2014 May;25(5):481. doi: 10.1097/CAD.0000000000000078. Anticancer Drugs. 2014. PMID: 24705370 No abstract available.
Intraperitoneal Therapy for Ovarian Cancer.
Muggia FM. Muggia FM. J Clin Oncol. 2016 Mar 10;34(8):882. doi: 10.1200/JCO.2015.62.8370. Epub 2016 Feb 1. J Clin Oncol. 2016. PMID: 26834061 No abstract available.
Liposomal anthracycline treatment for ovarian cancer.
Markman M, Gordon AN, McGuire WP, Muggia FM. Markman M, et al. Among authors: muggia fm. Semin Oncol. 2004 Dec;31(6 Suppl 13):91-105. doi: 10.1053/j.seminoncol.2004.08.004. Semin Oncol. 2004. PMID: 15717739 Review.
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
Alberts DS, Muggia FM, Carmichael J, Winer EP, Jahanzeb M, Venook AP, Skubitz KM, Rivera E, Sparano JA, DiBella NJ, Stewart SJ, Kavanagh JJ, Gabizon AA. Alberts DS, et al. Among authors: muggia fm. Semin Oncol. 2004 Dec;31(6 Suppl 13):53-90. doi: 10.1053/j.seminoncol.2004.08.010. Semin Oncol. 2004. PMID: 15717738 Review.
58 results